

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Greenpeace Germany announced today that it is suing Volkswagen, the world's second largest car manufacturer, for failing to decarbonise the company in line with the 1.5degC goal agreed in Paris. Based on the most recent reports by the Intergovernmental Panel on Climate Change (IPCC) and the International Energy Agency (IEA), the independent environmental organisation demanded the company end the production of climate-damaging internal combustion vehicles and reduce its carbon footprint by 65% by 2030 at the latest.
By holding Volkswagen accountable for the consequences of its climate-damaging business model, Greenpeace Germany is enforcing the landmark Karlsruhe constitutional court ruling of April 2021, when the judges ruled that future generations have a fundamental right to climate protection. Large companies are equally bound by this requirement.
Martin Kaiser, Executive Director of Greenpeace Germany, said: "While people suffer from floods and droughts triggered by the climate crisis, the car industry, despite its enormous contribution to global warming, seems unaffected. The ruling of the Constitutional Court represents a mandate to quickly and effectively enforce the legal protection of our common livelihoods. We need all hands on deck to protect our common future."
In its letter to Volkswagen preceding the filing with the court, Greenpeace Germany claims that the company's current and planned measures contravene the Paris climate goals, fuel the climate crisis and thus violate applicable law. Disregarding the need to rapidly phase out the internal combustion engine to be able to stay below 1.5degC, Volkswagen continues to sell millions of climate-damaging diesel and petrol cars, causing a carbon footprint almost equivalent to Australia's total annual emissions, contributing to increase extreme weather events, according to a research by Greenpeace Germany.
The plaintiffs, including Fridays for Future activist Clara Mayer, are asserting civil liability claims for the protection of their personal liberties, health and property rights, based on the May 2021 Dutch Court case against Shell, which ruled that large corporations have their own climate responsibility and ordered Shell and all its subsidiaries to do more to protect the climate.
Notes
Greenpeace Germany is represented by Dr. Roda Verheyen. The Hamburg-based attorney was already legal counsel for the nine plaintiffs in the climate lawsuit against the German government, which ended with the successful ruling of the Federal Constitutional Court in April 2021 and is also leading the claim against RWE brought by a Peruvian farmer since 2015.
Greenpeace Germany is appearing today, 3 September 2021, together with Deutsche Umwelthilfe (DUH) at the Federal Press Conference in Berlin. In addition, DUH today initiated proceedings against the other two major German carmakers, Mercedes-Benz and BMW, demanding a climate strategy that complies with the Paris Agreement goals. DUH also announced legal action against the oil and natural gas company Wintershall Dea.
The suit is launched only days before the start of the Internationale Automobil-Ausstellung (IAA), one of the largest Car Shows in the world due to open on 7 September 7 in Munich. Greenpeace Germany as part of a large NGO alliance is organising a large protest march and bike ride against the car and internal combustion engine-centred industry.
Quotes
Roda Verheyen, counsel for the plaintiffs: "Whoever delays climate protection harms others and thus behaves unlawfully. This is clear on the basis of the constitutional court decision, and this also and especially applies to the German car industry with its gigantic global CO2 footprint. Clearly, this is not a game. Civil law can and must help us to prevent the worst effects of climate change by ordering corporations to stop emitting - otherwise they endanger our lives and deprive our children and grandchildren of the right to a safe future."
Clara Mayer, plaintiff against Volkswagen and climate protection activist, said: "Climate protection is a constitutional right. It is not acceptable that a company should so significantly prevent us from reaching our climate targets. At the moment, Volkswagen is making huge profits by producing climate-damaging cars, which we will have to pay dearly for in the form of climate consequences. The basic rights of future generations are in danger, as we are already seeing the effects of the climate crisis. The begging and pleading has come to an end, it is time to hold Volkswagen legally responsible."
Links
The claim letter from Greenpeace in German can be found at https://bit.ly/3mV05Hn.
Further information on the claim at https://www.greenpeace.de/themen/energiewende/mobilitaet/auf-klimaschutz-verklagt
Contacts
Benjamin Stephan, transport expert Greenpeace Germany, mobile +49151-57208151, Benjamin.Stephan@greenpeace.org
Simone Miller, Press Officer Greenpeace Germany, mobile +49171-8706647, Simone.Miller@greenpeace.org
Photo desk Eva Petschull, +49174-1313323, pictures available here
Greenpeace is a global, independent campaigning organization that uses peaceful protest and creative communication to expose global environmental problems and promote solutions that are essential to a green and peaceful future.
+31 20 718 2000"The truth is, there are not enough factories, or skilled workers, or materials to effectively spend such a huge increase," said one expert. "It will be a recipe for waste, fraud, and abuse."
The budget document that President Donald Trump's White House is set to release Friday calls for $1.5 trillion in military spending for the coming fiscal year, an unprecedented sum that—if approved by Congress—would add nearly $7 trillion to the US national debt over the next decade.
The Wall Street Journal's editorial board, which got an early look at the president's fiscal year 2027 budget, reported that the plan includes roughly $1.15 trillion in baseline US military spending as well as $350 billion in supplemental funding "that Republicans could pass in a party-line budget reconciliation bill." The Journal doesn't specify the purpose of the proposed supplemental funding, but the Pentagon has asked Congress for at least $200 billion for the Iran war.
The budget, which would boost total US military spending by more than 40% compared to the current fiscal year, also reportedly calls for investments in Trump's so-called Golden Dome missile defense system, a project that critics have derided as an absurd boondoggle.
Earlier this week, Trump suggested the US federal government can't afford to fund childcare and other domestic social programs because it is "fighting wars."
William Hartung, a senior research fellow at the Quincy Institute for Responsible Statecraft, wrote in an analysis of the budget proposal ahead of its official release that "whatever vehicles the administration chooses to promote this huge increase, it will be doubling down on a failed budgetary and national security strategy."
"If passed as requested, $1.5 trillion in Pentagon spending—in a single year–will make America weaker by underwriting a misguided strategy, funding outmoded weapons programs, and crowding out other essential public investments," Hartung argued. "The Pentagon doesn’t need more spending, it needs more spending discipline. Spending billions of dollars on a Golden Dome system that can never achieve the President’s dream of a leak-proof missile defense system is sheer waste, as is continuing to lavish funds on overpriced, underperforming combat aircraft like the F-35, or multi-billion dollar aircraft carriers that are vulnerable to modern high-speed missiles."
"The truth is, there are not enough factories, or skilled workers, or materials to effectively spend such a huge increase," he added. "It will be a recipe for waste, fraud, and abuse."
In anticipation of the White House proposal, a broad coalition of nearly 300 advocacy organizations sent a letter to members of Congress on Thursday demanding that they reject Trump's request and any other proposed budget increases for the Pentagon, which recently failed its eighth consecutive audit.
"We must invest in critical human needs programs in our communities. Instead, we have cut those programs massively," the groups wrote, pointing to the record Medicaid and nutrition assistance cuts that Trump and congressional Republicans approved last year.
"The Pentagon is unaccountable to American taxpayers, having never passed an audit, while more than half of its budget (54 percent) is paid to corporate military contractors, whose profits are rising. Further gigantic increases would be grossly irresponsible," the groups continued. "Funding an unaccountable Pentagon by more than $1 trillion while underfunding human needs programs undermines our security by preventing us from investing in the shared prosperity that comes from more housing, health care, climate and public health protections, ending hunger, and providing quality public education."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," one analyst wrote of the Trump administration's assault.
US President Donald Trump late Thursday threatened more illegal attacks on Iranian civilian infrastructure, including bridges and power plants, as Iran's military said it shot down an American fighter jet over Tehran, with state-affiliated media publishing apparent photos from the scene.
An Iranian official told Drop Site's Jeremy Scahill that Iran's forces hit an F-15 warplane, causing the jet to crash and sparking "an intense fire." The unnamed Iranian official said the pilot could not have evacuated due to the "nature of the strike," but "no remains have yet been found."
The US Central Command had not commented on the purported downing of an American fighter jet as of this writing. Last month, a US F-35 was forced to make an emergency landing at an air base in the Middle East after reportedly being struck by Iranian fire.
🚨 BREAKING | An Iranian official told Drop Site News that a U.S. F-15 warplane struck by Iranian forces went down over southern Tehran Province, with intense fire reported at the crash site.
The official said the nature of the strike prevented the pilot[s] from ejecting before… https://t.co/iUKD0AqRQQ pic.twitter.com/BI4TzolmZY
— Drop Site (@DropSiteNews) April 3, 2026
Iran's claim on Friday came as Trump issued more belligerent threats on his social media platform, declaring that the US military "hasn’t even started destroying what’s left in Iran."
"Bridges next, then Electric Power Plants!" the president wrote, shortly after bragging about the US military's destruction of an Iranian highway bridge. "New Regime leadership knows what has to be done, and has to be done, FAST!"
Brian Finucane, senior adviser to the US Program at the International Crisis Group, characterized Trump's message as "more threats of war crimes as POTUS flails and seeks to coerce an exit to his own self-inflicted, unnecessary, and ill-conceived war."
Trump's renewed threats came amid reports of US-Israeli attacks on a century-old Iranian medical research center, pharmaceutical facilities, residential buildings, and other civilian infrastructure—and on emergency responders aiding those wounded by the attacks.
"War crime after war crime after war crime," US Rep. Yassamin Ansari (D-Ariz.), the lone Iranian American member of Congress, wrote early Friday. "Now’s the time to speak up if you’re against this reckless war of choice. The consequences will be vast and catastrophic."
Ben Rhodes, a political analyst who worked in the Obama administration, wrote that the US military's recent actions have "nothing to do with nuclear or helping Iranians."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," Rhodes added.
One campaigner urged the administration to "focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
On Thursday, the one-year anniversary of President Donald Trump's so-called Liberation Day, US advocacy groups sounded the alarm about his new tariffs targeting "patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 to bolster American national security and public health."
The administration announced a year ago that the US Department of Commerce would conduct a related investigation under that law. The resulting report was recently sent to the president, and although the findings have not been made public, Trump's executive order summarizes key takeaways and Secretary Howard Lutnick's recommended actions.
According to the order, the secretary's recommendations included "continuing to negotiate onshoring agreements related to most favored nation (MFN) pharmaceutical pricing agreements; imposing significant tariffs on pharmaceuticals and pharmaceutical ingredients, so that such imports will not threaten to impair the national security of the United States; and granting preferential treatment to those companies that commit to onshore production of pharmaceuticals and pharmaceutical ingredients."
Citing an unnamed Trump administration official, The Washington Post reported Thursday that "the White House has reached agreements with 13 drugmakers and expects to soon conclude an additional four." As part of these deals, companies are planning to invest at least $400 billion in new US plants.
The Post also pointed out that "some imported drugs will face much lower tariffs under trade deals Trump negotiated with five US trading partners. Goods from the European Union, Japan, South Korea, and Switzerland will face 15% levies, while drugs from the United Kingdom, which was the first to sign a deal with Trump, will be hit with a 10% tariff."
Thanks to Trump's new order, brand-name pharmaceuticals made in other countries could be hit with tariffs as high as 100%.
Merith Basey, CEO of Patients for Affordable Drugs, warned in a statement that "while these tariffs aim to pressure pharmaceutical corporations into US manufacturing and most favored nation agreements, the current MFN deals remain opaque and voluntary, and have not delivered meaningful savings for the vast majority of American patients. There's a real risk these tariffs will drive up costs and create more uncertainty for millions of patients already struggling to afford their medications."
Experts at Public Citizen, another advocacy group that has sued to expose the secretive MFN agreements, were similarly critical.
"By announcing these tariffs without even producing the evidence from the investigation that supposedly justifies them, Trump is continuing his pattern of grabbing headlines by using the word 'tariff' while engaging in secretive ongoing negotiations and opaque exemptions processes that are ripe for corporate corruption," said Public Citizen Global Trade Watch director Melinda St. Louis—who also wrote a broader takedown of Trump's trade policy published Thursday by Common Dreams.
"While strategic tariffs can be used to support domestic manufacturing and good jobs, they must be paired with real public investments and support for workers' rights, which Trump has systematically undermined," she said. "Instead, he's bullying other countries like the UK into paying more for medicines, which will lead to windfall profits for Big Pharma and do nothing to reduce US prices."
Peter Maybarduk, director of Access to Medicines at Public Citizen, stressed that "Trump's tariffs will be either ineffective or harmful for what people need, which is a reliable, plentiful, affordable supply of medicine."
Also taking aim at the "secretive arrangements that allow Trump to claim specious victories on manufacturing and high drug prices," Maybarduk explained that "in reality, many manufacturing commitments claimed under the deals were part of previously planned projects and the drug pricing commitments appear designed to largely spare drug company profits rather than earnestly address affordability concerns."
"Meanwhile the administration has given drugmakers perks like lucrative vouchers to accelerate FDA review of their medicines and a promise from the Trump administration that it will bully other countries into adopting higher prescription drug prices, using tariffs as leverage," he continued, referring to the Food and Drug administration.
"If the administration wants to fix problems like medicines shortages and fragile supply chains," he argued, "it should focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."